Medicare Part D Drug Coverage List

According to the Centers for Medicare & Medicaid Services (CMS) 2026 Part D formulary data, this list covers 6,046 drugs across Medicare Part D plans, sorted by how broadly each is covered. Under the Inflation Reduction Act, Part D out-of-pocket costs are capped at $2,000 a year in 2026; see our methodology for how coverage breadth is calculated.

Coverage varies by plan and geography. Verify drug coverage with your specific plan before making decisions.

Overview Browse Drugs Part D Plans Rankings

Drug Name	Plans Covering	Coverage %	Avg Tier	PA %	2023 Benes
0.72 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe [Fragmin] dalteparin sodium	856	16.9%	T4	0%	87
olanzapine 10 MG Injection [Zyprexa] olanzapine	855	16.9%	T4	12.5%	516,737
ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet ledipasvir	855	16.9%	T4	100%	691
0.2 ML dalteparin sodium 12500 UNT/ML Prefilled Syringe [Fragmin] dalteparin sodium	855	16.9%	T4	0%	87
0.2 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe [Fragmin] dalteparin sodium	855	16.9%	T4	0%	87
glycopyrrolate 0.2 MG/ML Oral Solution glycopyrrolate	854	16.9%	T2	2.4%	51,524
0.3 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe [Fragmin] dalteparin sodium	852	16.8%	T4	0%	87
odevixibat 0.4 MG Oral Capsule [Bylvay] odevixibat	846	16.7%	T4	100%	-
odevixibat 1.2 MG Oral Capsule [Bylvay] odevixibat	846	16.7%	T4	100%	-
buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] buprenorphine	843	16.6%	T3	0%	74,893
buprenorphine 4 MG / naloxone 1 MG Sublingual Film [Suboxone] buprenorphine	843	16.6%	T3	0%	74,893
buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone] buprenorphine	843	16.6%	T3	0%	74,893
buprenorphine 12 MG / naloxone 3 MG Sublingual Film [Suboxone] buprenorphine	843	16.6%	T3	0%	74,893
desoximetasone 0.5 MG/ML Topical Cream desoximetasone	843	16.6%	T3	0%	27,754
odevixibat 0.2 MG Oral Pellet [Bylvay] odevixibat	843	16.6%	T4	100%	-
odevixibat 0.6 MG Oral Pellet [Bylvay] odevixibat	843	16.6%	T4	100%	-
echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] echothiophate iodide	841	16.6%	T4	0%	50
24 HR topiramate 100 MG Extended Release Oral Capsule topiramate	836	16.5%	T4	21.1%	-
24 HR topiramate 25 MG Extended Release Oral Capsule topiramate	836	16.5%	T4	21.1%	-
24 HR topiramate 50 MG Extended Release Oral Capsule topiramate	836	16.5%	T4	21.1%	-
pitavastatin calcium 1 MG Oral Tablet [Livalo] pitavastatin calcium	834	16.5%	T3	0%	70,926
pitavastatin calcium 2 MG Oral Tablet [Livalo] pitavastatin calcium	834	16.5%	T3	0%	70,926
pitavastatin calcium 4 MG Oral Tablet [Livalo] pitavastatin calcium	834	16.5%	T3	0%	70,926
1.5 ML somatropin 3.33 MG/ML Pen Injector [Norditropin] somatropin	834	16.5%	T4	100%	-
1.5 ML somatropin 6.67 MG/ML Pen Injector [Norditropin] somatropin	834	16.5%	T4	100%	-
1.5 ML somatropin 10 MG/ML Pen Injector [Norditropin] somatropin	834	16.5%	T4	100%	-
deflazacort 6 MG Oral Tablet deflazacort	833	16.4%	T5	96.2%	99
deflazacort 18 MG Oral Tablet deflazacort	833	16.4%	T5	96.2%	99
deflazacort 30 MG Oral Tablet deflazacort	833	16.4%	T5	96.2%	99
deflazacort 36 MG Oral Tablet deflazacort	833	16.4%	T5	96.2%	99
dextroamphetamine sulfate 1 MG/ML Oral Solution dextroamphetamine sulfate	832	16.4%	T4	0%	9,950
carbinoxamine maleate 0.8 MG/ML Oral Solution carbinoxamine maleate	828	16.3%	T2	75%	1,400
cephalexin 250 MG Oral Tablet cephalexin	827	16.3%	T2	0%	5,051,787
24 HR topiramate 200 MG Extended Release Oral Capsule topiramate	825	16.3%	T4	21.1%	-
progesterone 0.08 MG/MG Vaginal Gel [Crinone] progesterone	824	16.3%	T3	100%	109
roflumilast 3 MG/ML Topical Cream [Zoryve] roflumilast	821	16.2%	T4	100%	59,491
1 ML glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone] glatiramer acetate	819	16.2%	T4	93.9%	6,385
deflazacort 22.75 MG/ML Oral Suspension deflazacort	819	16.2%	T4	95.8%	99
roflumilast 3 MG/ML Topical Foam [Zoryve] roflumilast	818	16.1%	T4	100%	59,491
aprepitant 125 MG Powder for Oral Suspension [Emend] aprepitant	814	16.1%	T3	100%	4,705
timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] timolol hemihydrate	809	16%	T4	0%	6,978
mycophenolate mofetil 200 MG/ML Oral Suspension [Myhibbin] mycophenolate mofetil	807	15.9%	T4	100%	105,503
24 HR pramipexole dihydrochloride 0.75 MG Extended Release Oral Tablet pramipexole dihydrochloride	807	15.9%	T3	0%	-
cysteamine 3.8 MG/ML Ophthalmic Solution [Cystadrops] cysteamine	804	15.9%	T4	97%	30
24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet pramipexole dihydrochloride	798	15.7%	T3	0%	-
loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [Lotemax] loteprednol etabonate	791	15.6%	T4	0%	91,483
levonorgestrel 0.000583 MG/HR Intrauterine System [Skyla] levonorgestrel	788	15.6%	T3	0%	650
12 HR disopyramide 100 MG Extended Release Oral Capsule [Norpace] disopyramide	788	15.6%	T4	8%	11
12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace] disopyramide	788	15.6%	T4	8%	11
betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam [Enstilar] betamethasone dipropionate	786	15.5%	T4	93.3%	407,711
24 HR darifenacin 7.5 MG Extended Release Oral Tablet darifenacin	785	15.5%	T3	0%	-
24 HR darifenacin 15 MG Extended Release Oral Tablet darifenacin	785	15.5%	T3	0%	-
ledipasvir 45 MG / sofosbuvir 200 MG Oral Pellet [Harvoni] ledipasvir	779	15.4%	T4	100%	691
ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet [Harvoni] ledipasvir	779	15.4%	T4	100%	691
deflazacort 6 MG Oral Tablet [Jaythari] deflazacort	777	15.3%	T4	91.7%	99
deflazacort 18 MG Oral Tablet [Jaythari] deflazacort	777	15.3%	T4	91.7%	99
deflazacort 30 MG Oral Tablet [Jaythari] deflazacort	777	15.3%	T4	91.7%	99
deflazacort 36 MG Oral Tablet [Jaythari] deflazacort	777	15.3%	T4	91.7%	99
colchicine 0.6 MG Oral Capsule colchicine	775	15.3%	T2	0%	553,640
loteprednol etabonate 5 MG/ML Ophthalmic Suspension [Lotemax] loteprednol etabonate	775	15.3%	T4	0%	91,483
bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] bepotastine besilate	775	15.3%	T4	0%	19,677
daridorexant 25 MG Oral Tablet [Quviviq] daridorexant	775	15.3%	T4	0%	10,838
daridorexant 50 MG Oral Tablet [Quviviq] daridorexant	775	15.3%	T4	0%	10,838
cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [Oxervate] cenegermin-bkbj	774	15.3%	T4	100%	3,526
ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet [Harvoni] ledipasvir	774	15.3%	T4	100%	691
ledipasvir 45 MG / sofosbuvir 200 MG Oral Tablet [Harvoni] ledipasvir	771	15.2%	T4	100%	691
auranofin 3 MG Oral Capsule [Ridaura] auranofin	767	15.1%	T3	0%	91
trimethobenzamide hydrochloride 300 MG Oral Capsule trimethobenzamide hydrochloride	765	15.1%	T2	23.1%	143
fenofibrate 150 MG Oral Capsule fenofibrate	762	15%	T2	0%	500,170
carbinoxamine maleate 4 MG Oral Tablet carbinoxamine maleate	760	15%	T2	73.3%	1,400
10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] immune	758	15%	T4	100%	219
alprazolam 1 MG/ML Oral Solution alprazolam	757	14.9%	T3	26.9%	2,265,351
fenofibrate 40 MG Oral Tablet fenofibrate	757	14.9%	T3	0%	500,170
treprostinil 0.0265 MG Inhalation Powder [Yutrepia] treprostinil	756	14.9%	T4	97%	3,017
treprostinil 0.053 MG Inhalation Powder [Yutrepia] treprostinil	756	14.9%	T4	97%	3,017
treprostinil 0.0795 MG Inhalation Powder [Yutrepia] treprostinil	756	14.9%	T4	97%	3,017
treprostinil 0.106 MG Inhalation Powder [Yutrepia] treprostinil	756	14.9%	T4	97%	3,017
{5 (dienogest 2 MG / estradiol valerate 2 MG Oral Tablet) / 17 (dienogest 3 MG / estradiol valerate 2 MG Oral Tablet) / 2 (estradiol valerate 1 MG Oral Tablet) / 2 (estradiol valerate 3 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Natazia 28 Day] dienogest	754	14.9%	T3	0%	-
doxepin hydrochloride 50 MG/ML Topical Cream doxepin hydrochloride	753	14.9%	T3	69.2%	276,316
120 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler	747	14.7%	T2	0%	-
120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler	747	14.7%	T2	0%	-
120 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler	747	14.7%	T2	0%	-
1 ML glatiramer acetate 20 MG/ML Prefilled Syringe [Copaxone] glatiramer acetate	745	14.7%	T4	93.8%	6,385
insulin glargine-yfgn 100 UNT/ML Injectable Solution insulin glargine-yfgn	744	14.7%	T3	0%	122,201
3 ML insulin glargine-yfgn 100 UNT/ML Pen Injector insulin glargine-yfgn	744	14.7%	T3	0%	-
25 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] immune	741	14.6%	T4	100%	219
50 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] immune	741	14.6%	T4	100%	219
100 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] immune	741	14.6%	T4	100%	219
200 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] immune	741	14.6%	T4	100%	219
300 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] immune	741	14.6%	T4	100%	219
1.7 ML denosumab-nxxp 70 MG/ML Injection [Bilprevda] denosumab-nxxp	740	14.6%	T5	85.7%	-
{2 (480 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack [Suprep Bowel Prep Kit]	739	14.6%	T3	0%	-
ketoconazole 20 MG/ML Topical Foam ketoconazole	734	14.5%	T3	0%	1,750,875
doxycycline monohydrate 150 MG Oral Capsule doxycycline monohydrate	734	14.5%	T3	0%	1,315,899
clobetasol propionate 0.5 MG/ML Topical Lotion clobetasol propionate	733	14.5%	T2	0%	1,250,981
zolmitriptan 5 MG Disintegrating Oral Tablet zolmitriptan	730	14.4%	T2	0%	11,158
lactulose 10000 MG Powder for Oral Solution lactulose	726	14.3%	T4	41.2%	526,962
hydrocortisone butyrate 1 MG/ML Topical Cream hydrocortisone butyrate	721	14.2%	T3	0%	6,139
Sprinkle 24 HR topiramate 50 MG Extended Release Oral Capsule Sprinkle	720	14.2%	T3	5.3%	-
Sprinkle 24 HR topiramate 150 MG Extended Release Oral Capsule Sprinkle	719	14.2%	T3	5.6%	-

← Previous Page 42 of 61 Next →

Source: CMS Quarterly Prescription Drug Plan Formulary PUF 2026. 6,046 drugs with RXCUI identifiers from NLM RxNorm. Coverage percentages based on 0 active Part D plans.

Compiled by Plainmedicare Editorial, Health Insurance Editorial Team